3 ms·
But these candidates are all competing! It’s like if Netscape was never open sourced, we would have closed source browser wars, all our explosion of wealth was
by EGreg 6y ago
But these candidates are all competing! It’s like if Netscape was never open sourced, we would have closed source browser wars, all our explosion of wealth was BECAUSE of that happy accident. Once anyone is free to build on them, we could have a lot more drugs. Many drugs were repurposed, as well. Viagra was not designed for its current use case. Methamphetamines are strikingly similar to cocaine. Imagine how much innovation could be done if people were ALLOWED to do it!
- jcranmer 6y agoAnyone can do it! When you patent a drug, you patent a compound for the purpose it is being used for. If you use it for a different purpose, then you won't violate the patent. So why don't we see more repurposing of drugs? Because it's expensive to actually go through all of the clinical trials, especially the final Phase III trial (where 50% of drugs fail due to being ineffective).
- EGreg 6y agoSeriously? Have you read the doctrine of equivalents? https://en.wikipedia.org/wiki/Doctrine_of_equivalents https://en.wikipedia.org/wiki/Doctrine_of_equivalents And moreover, patented drugs are repurposed all the time and always by their original developers. Show me a counterexample!
- vikramkr 6y agotechnically you patent the molecular structure too, and then take out a cloud of dozens of patents around it, while getting as broad language as possible (used for any disease where the pathology is influenced by this molecule, or whatever uspto will let you get away with) But generics companies are heavily incentivized to try and overturn those patents by law, and drugs are repurposed all the time through off label use without a phase III for the indication.
- vikramkr 6y agoyou think the reason that a drug fails a clinical trial is because of ... competition? Like, Bayer's aspirin is just going to stop curing headaches because it's angry that J&J is developing Tylenol? A drug that doesn't work isn't going to start working if it becomes open source, that's not really how chemistry works
- EGreg 6y agoActually, if someone else could build on all the results of all the failed clinical trials, realize it works offlabel for something else or change one atom and make it work as a generic drug... that could help tons of people. Instead they change one atom on working drugs and extend patents another 17 years.
- vikramkr 6y agoChanging an atom is a big deal, thats a whole other drug. Evergreens, where they extend patents through small modifications, has nothing to do with the active ingredient since changing that requires another few hundred million dollars in clinical trials. And generics companies are already incentivized by law to sue and overturn patents. I would suggest spending time to learn about what these problems like evergreening actually are, and how drug development actually works from a scientific perspective, before trying to come up with societal structures to do it better. I would also recommend then reading up on the current societal structures so you can get a sense of what off label use actually means, what that entails, how generics companies work, what their incentives are, and so on. But start with the science behind how drugs and drug development works, the statistics of why clinical trials are needed, etc, since you really can't do anything without that basis.